InCarda Therapeutics, Inc. — Form D
InCarda Therapeutics, Inc. of NEWARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-05-02. The offering totals $2.5M, of which $2.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-05-02
- Form: D
- Accession: 0001552622-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.1M
- Remaining: $365K
- Minimum investment: $5K
- Investors: 16
- Date of first sale: 2017-03-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-285853
Issuer
- Name: InCarda Therapeutics, Inc.
- CIK: 0001552622
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 39899 BALENTINE DRIVE, SUITE 185, NEWARK, CA, 94560
- Phone: 408-219-2576
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Rangachari Narasimhan | Director | Brisbane, CA |
| McCarthy Reenie | Director | Brisbane, CA |
| Rangachari Narasimhan | Executive Officer | Brisbane, CA |
| Miller Samantha | Executive Officer | Brisbane, CA |
| Alan Colowick | Director | Belmont, CA |
| Andrew ElBardissi | Director | St. Louis Park, MN |
| John S Patton | Director | Durham, NC |
| John S Patton | Executive Officer | Durham, NC |
| Isaac Cheng | Director | Portland, ME |
| Johan Christenson | Director | NEWARK, CA |
| Grace Colon | Director | NEWARK, CA |
| Grace Colon | Executive Officer | NEWARK, CA |
| Dan Welch | Director | NEWARK, CA |
| Bischofberger Norbert | Director | Newark, CA |
| Grace S Colon | Director | San Francisco, CA |
| Grace S Colon | Executive Officer | San Francisco, CA |
| Carlos A Schuler | Director | San Francisco, CA |
| Carlos A Schuler | Executive Officer | San Francisco, CA |
Other filings by this issuer (5)
More